-
Why Boards Often Realise the Value of a CMO Too Late
Clinical leadership in MedTech is rarely treated as a strategic variable at the start. In early stages, it often appears procedural. A role associated with compliance, trials, and regulatory navigation. Certainly treated as important but not always central to valuation. That perception tends to change when the inevitable pressure mounts. As scale approaches, clinical judgement…
-
MHRA Proposes Indefinite Recognition of CE Marked Medical Devices in Great Britain
You did not build your company to spend its best energy navigating paperwork. You built it to move something that matters, a device, an idea, a breakthrough, from concept to clinic and from prototype to patient. The ambition has always been clear: to get life-saving products into the hands of clinicians efficiently, without unnecessary friction…
-
When Boards Confuse Assurance With Control
Boards rarely seek control for its own sake. They seek reassurance that control exists. In regulated MedTech environments, that instinct is responsible. Decisions carry consequences, timelines compound exposure, and oversight is not optional. Assurance is how boards demonstrate care without pretending certainty is possible. The difficulty begins when assurance quietly takes on a second role.…
-
How Boards Misread Technical Risk
When Everything Sounds Reasonable Most boards believe they have good visibility on technical risk. They usually do, just not early enough. In well‑run MedTech organisations, risk almost never shows up as failure first. What it shows up as is reassurance. Milestones are being hit. The team sounds confident when they talk it through. The board…
ai, artificial-intelligence, Board oversight of engineering risk, business, Early vs late technical risk decisions, How boards assess technical risk in MedTech, How MDR and IVDR exposed governance gaps, Leadership alignment MedTech, MedTech board governance, MedTech board oversight, MedTech technical risk, Regulatory risk MedTech, Technical leadership risk, Technical risk governance, Technical risk in regulated healthcare, Technical risk visibility at board level, technology, Why MedTech boards miss early technical risk
-
The Leadership Gap MedTech Will Feel Before It Can Measure
In the coming years, many MedTech organisations will experience delays, friction, and regulatory setbacks that do not feel like failures. They will feel like bad luck. A certification that takes longer than expected. A product that stalls late in development. A launch window that quietly slips. In most cases, the root cause will not be…
ai, artificial-intelligence, business, CTO, How boards assess technical leadership, How MedTech leadership decisions affect regulation, leadership, Leadership risk in regulated healthcare, Leadership Strategy, management, MedTech, MedTech board advisory, MedTech CMO recruitment, MedTech CTO recruitment, MedTech executive hiring, MedTech leadership, MedTech leadership risk, Regulated MedTech leadership, Senior technical leadership MedTech, Tech Leadership, technology, Why MedTech hiring fails at senior level, Why MedTech launches get delayed
-
The Gap Between How AI Is Built and How It Will Be Assessed
Most AI MedTech companies are doing the right things, just in a way regulators will not recognise. Internally, everything feels controlled; externally, it will be judged by a very different standard. That gap widens fastest in companies moving quickly, led by capable teams who assume alignment will catch up later. But it rarely does. How…
-
The Most Dangerous Talent Blind Spot in Tech Leadership
The Hidden Leader Outside Your Field of Vision The next leader who will unlock growth for your company may be outside your current field of vision. You already know how much growth depends on the right technical leadership at the right moment. Some leaders operate in flow so deeply that they underestimate the scale of…
-
How Trusted Relationships Win the Race for Senior Technical Talent
The leaders organisations struggle most to find are rarely unavailable. They are simply already in conversation, long before a role is defined, with people they trust to protect their judgement as much as their opportunity. Why the Best Leaders Are Rarely “Unavailable” At this level, career decisions carry asymmetric risk. A single misstep can erode…
-
Why Most MedTech Leadership Pipelines Miss Their Best Candidates
Most medtech leadership pipelines are working exactly as intended, and that is why they so often miss the leaders who matter most. They are not broken, under-resourced, or poorly run. In many cases, they are carefully designed systems built to reduce risk, move efficiently, and surface candidates who feel safe to appoint. That intention makes…
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Harun Rabbani 